U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                   FORM 10-QSB



             QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                 For the quarterly period ended: March 31, 2001


                         Commission file number: 0-28154



                             SMLX TECHNOLOGIES, INC.
        -----------------------------------------------------------------
        (Exact name of small business issuer as specified in its Charter)



             Colorado                                   84-1337509
    -------------------------------         -------------------------------
   (State or other jurisdiction of                  (I.R.S. Employer
   incorporation or organization)                  Identification No.)


                855 SOUTH FEDERAL HIGHWAY, BOCA RATON, FL. 33432
          ------------------------------------------------------------
          (Address of principal executive offices, including zip code)


                                 (561) 347-0761
                           ---------------------------
                           (Issuer's telephone number)


Indicate by check mark whether the Issuer (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Exchange Act during the past 12
months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the
past 90 days.

                             Yes [ X ]   No [   ]


There were 12,004,648 shares of the Registrant's Common Stock outstanding as
of May 15, 2001.



INDEX


Part I: Financial Information                                           Page No.

Item 1. Financial Statements:

     Unaudited Consolidated Balance Sheets - as of
     December 31, 1999...........................................         3-4

     Unaudited Consolidated Statements of Operations, Three
     Months Ended March 31, 2000 and March 31, 1999 .............          5

     Unaudited Consolidated Statement of Cash Flows, Three
     Months Ended March 31, 2000 and March 31, 1999 ..............         6

     Notes to Consolidated Financial Statements...................        7-8

Item 2. Management's Discussion and Analysis of
        Financial Condition and Results of Operations ............         9

Part II: Other Information........................................        10

     Item 1.  Legal Proceedings...................................        10

     Item 2.  Change in Securities................................        10

     Item 3.  Defaults Upon Senior Securities.....................        10

     Item 4.  Submission of Matters to a Vote
              of Security Holders.................................        10

     Item 5.  Other Information...................................        10

     Item 6.  Exhibits and Reports on Form 8-K....................        10

Signatures .......................................................        10



                                    2


                          PART I: FINANCIAL INFORMATION
ITEM I:  FINANCIAL STATEMENTS

                     SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                           CONSOLIDATED BALANCE SHEETS
                                   (UNAUDITED)


ASSETS
                                                  3/31/01         12/31/00
                                               ------------     ------------

CURRENT ASSETS
  Cash                                        $     36,797     $      8,799
  Accounts Receivable (Net of allowance
    for uncollectible accounts of -0-
    and for 12/31/00 and 3/31/01,
    respectively)                                    2,400            6,164
  Inventory                                        178,441          150,092
  Prepaid Expenses                                  26,287           17,918
                                               ------------     ------------
     Total Current Assets                          243,925          182,973
                                               ------------     ------------

Property, Plant and Equipment, at cost
 (Net of accumulated depreciation and
 amortization of $325,739 and $300,199
 on 03/31/01 and 12/31/00, respectively)           341,867          333,762

OTHER ASSETS

  Deposits                                           7,862           10,862
  Other Intangible Assets                            1,890              276
  Patents and Trademarks
   (Net of accumulated amortization of $6,328
   and $2,439 on 03/31/01 and 12/31/00,
   respectively)                                   132,184          135,914
  Investment in Common Stock                       100,000          100,000
                                               ------------     ------------

Total Assets                                  $    827,728     $    763,787
                                               ============     ============



The  accompanying  notes are an integral  part of these  consolidated  financial
statements.


                                      3



                   SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                        CONSOLIDATED BALANCE SHEETS

                                 (UNAUDITED)

LIABILITIES AND STOCKHOLDERS' EQUITY
                                                    3/31/01         12/31/00
                                                 ------------     ------------

CURRENT LIABILITIES
  Accounts Payable and Accrued Liabilities       $    569,408     $    391,113
  Current Portion of Notes Payable                     10,406           15,646
  Customer Deposits                                       -0-           16,100
                                                 ------------     ------------
     Total Current Liabilities                        579,814          422,859

LONG-TERM DEBT
  Notes Payables, and accumulated expenses,
  Net of Current Portion                              506,781          526,781
COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY
  Common Stock (Par Value $.0001, Authorized
   100,000,000 Shares, Issued and Outstanding
   12,004,648 Shares on 3/31/01 and 12,004,648          1,154            1,154
   on 12/31/00)
  Preferred Stock (Par Value $.0001, Authorized
   10,000,000 Shares, No Shares Issued and
   Outstanding)                                            -                -
  Additional Paid-In Capital                        2,450,516        2,438,207
  Deficit Accumulated                              (2,710,539)      (2,625,214)
                                                 ------------     ------------
     Total Stockholders' Equity                      (258,868)         185,853
                                                 ------------     ------------
Total Liabilities and Stockholders' Equity       $    827,726     $    763,787
                                                 ============     ============



The  accompanying  notes are an integral  part of these  consolidated  financial
statements.


                                      4


                    SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                     CONSOLIDATED STATEMENT OF OPERATIONS
                                 (UNAUDITED)



                                                   THREE MONTHS ENDED
                                                3/31/01          3/31/00
                                             ------------     ------------
OPERATING REVENUE
  VECTOR TRANSDERMAL TECHNOLOGY                 225,000          225,000
  VECTOR COSMECUTIAL TECHNOLOGY                  75,000           50,000
  AIRBRATOR SALES                                32,348          274,604
  OTHER                                          43,140           23,296

     TOTAL OPERATING REVENUES              $    375,488     $    572,900

 COST OF GOODS SOLD                              73,184          126,863
                                           ------------     ------------

GROSS PROFIT                                    302,304          446,037
OPERATING EXPENSES
 SELLING, GENERAL AND ADMINISTRATIVE





     TOTAL OPERATING EXPENSES                   367,683          237,381

OPERATING PROFIT (LOSS)                         (65,379)         208,656

INTEREST EXPENSE                                 (7,635)         (7,644)
                                            ------------    ------------
NET PROFIT (LOSS)                               (73,013)         201,012

NET PROFIT (LOSS) PER SHARE                      (0.006)           0.017

WEIGHTED AVERAGE NUMBER OF
  SHARES OUTSTANDING                         12,004,648       12,004,648



The  accompanying  notes are an integral  part of these  consolidated  financial
statements.


                                      5


                     SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)

                                                        THREE MONTHS ENDED
                                                     3/31/01          3/31/00
                                                 -------------     ------------

CASH FLOWS FROM OPERATING ACTIVITIES:

  Net Profit (Loss)                              $    (73,013)     $    201,012

  Adjustment to Reconcile Net (Loss) to
   Net Cash Provided By (Used in)
   Operating Activities:

    Depreciation and Amortization                      27,775           23,592

    Changes in Operating Assets and
     Liabilities:
      Accounts Receivable                               3,764            6,071
      Inventory                                       (28,349)        (44,712)
      Deposits                                          3,000              500
      Accounts Payable and Accrued Liabilities        178,295            5,434
      Customer Deposits                               (16,100)       (108,780)
      Prepaid Expenses and Organization
       Expenses                                        (8,369)         (5,156)
                                                  ------------     ------------
     Net Cash (Used In) Provided By Operating
      Activities                                       87,063           77,961

CASH FLOWS FROM INVESTING ACTIVITIES:
  Acquisition of Fixed Assets                         (33,645)        (15,963)
  Patent Costs                                           (120)        (20,230)
                                                  ------------     ------------
     Net Cash Provided by (Used In)
      Investing Activities                            (33,765)        (36,193)

CASH FLOWS FROM FINANCING ACTIVITIES:
  Proceeds from Notes Payable                         (25,240)          14,291
                                                  ------------     ------------

Net Cash Provided By (Used In) Financing
  Activities                                          (25,240)          14,291
                                                  ------------     ------------

Net Increase (Decrease) in Cash                        27,998           56,059

Cash - Beginning of Period                              8,799          215,026
                                                  ------------     ------------
Cash - End of Period                             $     36,797     $    271,085
                                                  ============     ============



The  accompanying  notes are an integral  part of these  consolidated  financial
statements.

                                        6


                      SMLX TECHNOLOGIES,INC. AND SUBISDIARY
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)

NOTE 1 - BASIS OF PRESENTATION

The   accompanying   unaudited   consolidated   financial   statements  of  SMLX
Technologies,  Inc. (the "Company") and its wholly-owned  subsidiaries,  Simplex
Medical Systems, Inc.(a Florida corporation) and Analyte Diagnostics, Inc., have
been prepared in  accordance  with the  instructions  and  requirements  of Form
10-QSB and,  therefore,  do not include all information and footnotes  necessary
for a fair presentation of financial position,  results of operations,  and cash
flows in  conformity  with  generally  accepted  accounting  principles.  In the
opinion  of  management,  such  financial  statements  reflect  all  adjustments
(consisting only of normal recurring accruals) necessary for a fair presentation
of the results of  operations  and  financial  position for the interim  periods
presented.  Operating  results  for the  interim  periods  are  not  necessarily
indicative  of the  results  that  may be  expected  for the  full  year.  These
financial  statements  should be read in conjunction  with the Company's  annual
report on Form 10-KSB.

These financial  statements give effect to the March 5, 1997 reverse acquisition
whereby Music Tones Ltd. (name subsequently  changed to Simplex Medical Systems,
Inc.) acquired all of the outstanding  common stock of Simplex Medical  Systems,
Inc. as if the transaction occurred on September 15, 1995.

NOTE 2 - BASIS OF PRESENTATION AND CONTINUED EXISTENCE

The  accompanying  financial  statements  have been  prepared  assuming that the
Company  will  continue as a going  concern.  Since  inception,  the Company has
experienced losses aggregating $2,710,539 and has been dependent upon loans from
stockholders  and other third  parties in order to satisfy  operations  to date.
Management  believes  that funds  generated  from  operations  will  provide the
Company  with  sufficient  cash flow  resources  to fund the  operations  of the
Company.  The financial statements do not include any adjustments to reflect the
possible future effects on the  recoverability  and  classification of assets or
the amounts and  classification of liabilities that may result from the possible
inability of the Company to continue as a going concern.

NOTE 3 - INVENTORY

Inventory consists of $178,441 of finished goods as of March 31, 2001.

NOTE 4 - PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consists of the following at March 31, 2001:

       Leasehold Improvements                           $ 188,806
       Office Furniture and Equipment                      50,502
       Lab Equipment                                      405,149
                                                        ---------
       Total Equipment                                    667,606
           Less:  Accumulated Depreciation                325,739
                                                        ---------
       Net Property, Plant and Equipment                $ 341,867
                                                        =========


                                      7



NOTE 5 - NOTES PAYABLE

       Interest Expense for the period ended
       March 31, 2001, amounted to:                     $   7,535
       Interest Expense for the period ended
       March 31, 2000, amounted to:                     $   7,644

NOTE 6 - INCOME TAXES

To date the  Company  has  incurred  tax  operating  losses  and  therefore  has
generated  no income tax  liabilities.  As of March 31,  2001,  the  Company has
generated net operating  loss carry  forwards  totaling  $(2,710,539)  which are
available to offset future  taxable  income,  if any,  through the year 2011. As
utilization  of such an  operating  loss for tax  purposes is not  assured,  the
deferred  tax  asset has been  fully  reserved  through  the  recording  of 100%
valuation allowance.

The components of the net deferred tax asset are as follows at March 31, 2001:

      Deferred Tax Assets:
         Net Operating Loss Carry forward          (2,710,539)

      Valuation Allowance                          (2,710,539)



                                      8


ITEM 2. MANAGEMENT'S DISCUSSION AND ANAYLSIS OF FINANCIAL CONDITIONS AND
        RESULTS OF OPERATIONS.

     This report  contains  forward-looking  statements that involve a number of
risks and uncertainties.  While these statements represent the Company's current
judgement in the future direction of the business,  such risks and uncertainties
could cause  actual  results to differ  materially  from any future  performance
suggested herein.  Certain factors that could cause results to differ materially
from those projected in the forward-looking  statements include timing of orders
and  shipments,  market  acceptance  of products,  ability to increase  level of
production,  impact of  government  requisitions,  availability  of  capital  to
finance growth and general economic conditions.

     The following  should be read in  conjunction  with the attached  Financial
Statements and Notes thereto of the Company.

RESULTS OF OPERATIONS  FOR THREE MONTHS ENDED MARCH 31, 2001 VERSUS THREE MONTHS
ENDED MARCH 31, 2000

     During the three months  ended March 31, 2001,  the Company had $375,688 in
revenue  compared  to $572,900 in revenue  during the  corresponding  prior year
period. The decrease in revenue was the result of lower sales of airbrators.

     Expenses  for the three months  ended March 31,  2001,  were  approximately
$340,000,  an  increase  of  approximately  $140,000  in  legal  bills  over the
corporations previous operation for the prior year.

LIQUIDITY AND CAPITAL RESOURCES

     As of March  31,  2001,  the  Company  had a  working  capital  deficit  of
approximately  ($335,889)  compared to  approximately A deficit of $(239,886) in
working  capital at December 31, 2000. The increase in deficit is due to the net
loses for the quarter.

     The Company presently has no material commitments for capital expenditures.

     During  2000,  the  government  of the  United  States of  America  filed a
complaint concerning a former product of the Company. The Simplex Rapid HIV Test
Kit, and whether the Kit was manufactured in accordance with good  manufacturing
practices and received FDA approval and clearances.  The Company, in cooperation
with the  government,  agreed to enter a guilty plea to a FDA  violation  in the
sale of the Kits. The government has  recommended  payment of a fine of $150,000
and restitution of $197,500. The Company was sentenced on April 30, 2001 and has
accrued a liability  of $347,500  at December  31, 2000 based on the  government
recommendation.



                                      9


                           PART II: OTHER INFORMATION

Item 1.  Legal Proceedings:

     None

Item 2.  Changes in Securities:

     During the quarter ended March 31, 2000,  the Company issued 460,000 shares
of its Common Stock which were not registered  under the Securities Act of 1933,
as amended.  The shares were issued pursuant to a writ of mandamus issued by the
Circuit  Court of Miami-Dade  County in connection  with a lawsuit filed against
the  Company  by John  Faro.  The  shares  are being  held in  escrow  pending a
resolution of various claims against Mr. Faro.

Item 3.  Defaults Upon Senior Securities:

     None.

Item 4.  Submission of Matters to a Vote of Security Holders:

     None.

Item 5.  Other Information:

     None.


Item 6.  Exhibits and Reports on Form 8-K:

    (a) Reports on Form 8-K:   None


                                  SIGNATURES

     Pursuant to the  requirements  of the  Securities and Exchange Act of 1934,
the  Registrant  has duly  caused  this Report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                      SMLX TECHNOLOGIES, INC.


Date:  May 15, 2001                   /s/ Kenneth H. Robertson
                                      Kenneth H. Robertson, President


Date:  May 15, 2001                   /s/ Joel Marcus
                                      Joel Marcus, Chief Financial
Officer



                                    10